RELAPSED LEUKEMIA
Clinical trials for RELAPSED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Drug combo aims to wipe out Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests whether adding a new drug called roginolisib to two standard drugs (venetoclax and rituximab) is safe and works better for people with chronic lymphocytic leukemia (CLL) that has come back or not responded to prior treatments. About 64 adults who have already tri…
Matched conditions: RELAPSED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated May 17, 2026 06:22 UTC
-
New cell infusion aims to prepare leukemia patients for life-saving transplant
Disease control Recruiting nowThis early-phase study tests whether adding a special type of immune cell infusion to chemotherapy can safely help prepare people with relapsed or refractory leukemia for a stem cell transplant. Only 5 participants will be enrolled to check for side effects like graft-versus-host…
Matched conditions: RELAPSED LEUKEMIA
Phase: PHASE1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC